Related references
Note: Only part of the references are listed.Barriers to hepatitis C treatment
Christopher E. McGowan et al.
LIVER INTERNATIONAL (2012)
A Randomized Controlled Trial of an Integrated Care Intervention to Increase Eligibility for Chronic Hepatitis C Treatment
Donna M. Evon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Sanjeev Arora et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Barriers to accessing care in patients with chronic hepatitis C: the impact of depression
D. M. Evon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Institute of Medicine Recommendations for The Prevention and Control of Hepatitis B and C
Abigail E. Mitchell et al.
HEPATOLOGY (2010)
Antiviral therapy for hepatitis C: why are so few patients being treated?
Michael L. Volk
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Hepatitis C treatment completion rates in routine clinical care
Adeel A. Butt et al.
LIVER INTERNATIONAL (2010)
Public Health Impact of Antiviral Therapy for Hepatitis C in the United States
Michael L. Volk et al.
HEPATOLOGY (2009)
Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents
J. Grebely et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Market uptake of new antiviral drugs for the treatment of hepatitis C
Beate Lettmeier et al.
JOURNAL OF HEPATOLOGY (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A systematic review of provider knowledge of hepatitis C: Is it enough for a complex disease?
Susan L. Zickmund et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: Do they alter their decision with time?
Omar S. Khokhar et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Social stigmatization and hepatitis C virus infection
S Zacks et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Variation in Hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom
J Parkes et al.
BMC PUBLIC HEALTH (2006)
What do patients consider when making decisions about treatment for hepatitis C?
L Fraenkel et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Hepatitis C virus-infected patients report communication problems with physicians
S Zickmund et al.
HEPATOLOGY (2004)
Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C
PJ Rowan et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Side effects of therapy for chronic hepatitis C
MW Russo et al.
GASTROENTEROLOGY (2003)
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
M Schaefer et al.
HEPATOLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Surprisingly small effect of antiviral treatment in patients with hepatitis C
Y Falck-Ytter et al.
ANNALS OF INTERNAL MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Management of hepatitis C patients by primary care physicians in the USA: results of a national survey
TM Shehab et al.
JOURNAL OF VIRAL HEPATITIS (2001)
Survey of hepatitis B and C in addiction treatment unit
VP Dhopesh et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2000)
Share Paper
